IL-5 plays a crucial role in eosinophilic pathophysiology and is proposed as a novel therapeutic target for hypereosinophilic syndrome and rare eosinophilic conditions (16, 17). The gene discussed is IL5; the disease is hypereosinophilic syndrome.